Article

MatchMiner: An open source platform for cancer precision medicine

2022-02-05

Abstract excerpt

The systematic deployment of next generation sequencing means patient tumors can be genomically profiled and specific genetic alterations can be targeted with precision medicine (PM) drugs. More therapeutic clinical trials are needed to test new PM drugs to advance precision medicine, however, the availability of comprehensive patient sequencing data coupled with complex clinical trial eligibility has made it chal...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: a9bd8826-dcf9-52e9-8f7f-40dc6afb8c9c
DOI: 10.1101/2022.02.02.22270186

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

MatchMiner: An open source platform for cancer precision medicineDOI 10.1101/2022.02.02.22270186Read

MatchMiner: An open source computational platform for real-time matching of cancer patients to precision medicine clinical trials using genomic and clinical criteriaSemantic proximity Read

OncoCTMiner: streamlining precision oncology trial matching via molecular profile analysisSemantic proximity Read

Implementing a data infrastructure for precision oncology projects leveraging REDCapSemantic proximity Read

A Prospective Comparative Evaluation of Automatic Trial Matching Tools in a Molecular Tumor BoardSemantic proximity Read

Automated eligibility screening and monitoring for genotype-driven precision oncology trials.Semantic proximity Read

The NCI-MATCH: A National, Collaborative Precision Oncology Trial for Diverse Tumor Histologies.Semantic proximity Read

AstraKit: Customizable, reproducible workflows for biomedical research and precision medicineSemantic proximity Read

Digital ECMT Cancer Trial Matching Tool: an Open Source Research Application to Support Oncologists in the Identification of Precision Medicine Clinical Trials.Semantic proximity Read

A Precision Oncology Platform to Support Genotype-Tailored Therapy Selection.Semantic proximity Read

Considerations of developing an NGS assay for clinical applications in precision oncology: The NCI-MATCH NGS assay experience.Semantic proximity Read

CAN-Scan: A multi-omic phenotype-driven precision oncology platform identifies prognostic biomarkers of therapy response for colorectal cancerSemantic proximity Read

From somatic variants towards precision oncology: Evidence-driven reporting of treatment options in molecular tumor boards.Semantic proximity Read